Skip to content

4Accepted Oct 20, 4:35 PM ET

CYTOKINETICS INC: director Edward M. Kaye MD received 195 shares

CYTKCYTOKINETICS INC

Accepted (ET)

4:35 PM

Oct 20, 2026

Filed

Oct 20, 2026

Documents

1

Size

4.5 KB

Summary

CYTOKINETICS INC: director Edward M. Kaye MD received 195 shares

Updated

What happened Edward M. Kaye MD, a director, received 195 shares as an award at $63.92 per share for $12,464, the filing says.

Key details

  • Transaction date and price: Oct 16, 2026 — award of 195 shares at $63.92 per share.
  • Shares owned after the transaction: not specified in the filing.
  • Footnote: director equity in lieu of cash retainer program (F1).
  • Filing date: Oct 20, 2026.

Why it may matter

  • This was an award/grant of shares, not an open-market purchase or sale.
  • The shares were issued under a director equity in lieu of cash retainer program, per the footnote.
  • The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing